A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis
Clinical trial NCT06068478 · COMPLETED
Trial details
- NCT number
- NCT06068478
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2025-04-02
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.